Pharmacokinetics (population and cerebrospinal fluid penetration) of gatifloxacin, levofloxacin, and ciprofloxacin in Vietnamese patients with tubercular meningitis.

Trial Profile

Pharmacokinetics (population and cerebrospinal fluid penetration) of gatifloxacin, levofloxacin, and ciprofloxacin in Vietnamese patients with tubercular meningitis.

Completed
Phase of Trial: Phase IV

Latest Information Update: 19 Oct 2011

At a glance

  • Drugs Ciprofloxacin (Primary) ; Gatifloxacin (Primary) ; Levofloxacin (Primary) ; Ethambutol; Isoniazid; Pyrazinamide; Rifampicin
  • Indications Tubercular meningitis
  • Focus Biomarker; Pharmacokinetics; Therapeutic Use
  • Most Recent Events

    • 19 Oct 2011 New source identified and integrated (ISRCTN: Current Controlled Trials).
    • 19 Oct 2011 Additional trial centers identified as reported by ISRCTN.
    • 19 Oct 2011 Actual end date Feb 2005 added as reported by ISRCTN.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top